Evidence map›Paper›PMID 32407631›Full record

ArticleJournal of proteome research2020

Block Design with Common Reference Samples Enables Robust Large-Scale Label-Free Quantitative Proteome Profiling.

Tong Zhang, Matthew J Gaffrey, Matthew E Monroe, Dennis G Thomas, Karl K Weitz, Paul D Piehowski, Vladislav A Petyuk, Ronald J Moore, Brian D Thrall, Wei-Jun Qian

Abstract read
In one paragraph

Article in Journal of proteome research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. ANPELA: Significantly Enhanced Quantification Tool for Cytometry-Based Single-Cell Proteomics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tong ZhangBiological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington 99352, United States.
Matthew J GaffreyBiological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington 99352, United States.
Matthew E MonroeBiological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington 99352, United States.
Dennis G ThomasBiological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington 99352, United States.ORCID 0000-0002-9209-8740
Karl K WeitzBiological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington 99352, United States.
Paul D PiehowskiBiological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington 99352, United States.
Vladislav A PetyukBiological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington 99352, United States.
Ronald J MooreBiological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington 99352, United States.ORCID 0000-0003-2806-2855
Brian D ThrallBiological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington 99352, United States.
Wei-Jun QianBiological Sciences Division, Pacific Northwest National Laboratory, Richland, Washington 99352, United States.ORCID 0000-0002-5393-2827

Funding

Equipment Supplement Request for a Research Resource for Ultra-sensitive High Throughput ProteomicsP41GM103493 · NIGMS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2012 to 2022
$22.6M
Pathways and Regulators Driving Progressive Islet Cell Dysfunction in Type 1 DiabetesR01DK122160 · NIDDK · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI ROHIT N. KULKARNI, CLAYTON E MATHEWS · 2019 to 2026
$3.7M
Key Events in Modulation of Lung Infection Susceptibility by NanomaterialsU01ES027292 · NIEHS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI QIAN, WEI-JUN · 2016 to 2020
$2.0M
NIDDK NIH HHS R01 DK122160NIEHS NIH HHS U01 ES027292NIGMS NIH HHS P41 GM103493
6 · The paper itself

Abstract

Label-free quantitative proteomics has become an increasingly popular tool for profiling global protein abundances. However, one major limitation is the potential performance drift of the LC-MS platform over time, which, in turn, limits its utility for analyzing large-scale sample sets. To address this, we introduce an experimental and data analysis scheme based on a block design with common references within each block for enabling large-scale label-free quantification. In this scheme, a large number of samples (e.g., >100 samples) are analyzed in smaller and more manageable blocks, minimizing instrument drift and variability within individual blocks. Each designated block also contains common reference samples (e.g., controls) for normalization across all blocks. We demonstrated the robustness of this approach by profiling the proteome response of human macrophage THP-1 cells to 11 engineered nanomaterials at two different doses. A total of 116 samples were analyzed in six blocks, yielding an average coverage of 4500 proteins per sample. Following a common reference-based correction, 2537 proteins were quantified with high reproducibility without any imputation of missing values from 116 data sets. The data revealed the consistent quantification of proteins across all six blocks, as illustrated by the highly consistent abundances of house-keeping proteins in all samples and the high levels of correlation among samples from different blocks. The data also demonstrated that label-free quantification is robust and accurate enough to quantify even very subtle abundance changes as well as large fold-changes. Our streamlined workflow is easy to implement and can be readily adapted to other large cohort studies for reproducible label-free proteome quantification.

Indexed as

ProteomeProteomicsChromatography, LiquidHumansMass SpectrometryReproducibility of ResultsTHP-1 CellsProteomeblock designcommon referenceslabel-free quantificationlarge-scalemass spectrometryquantitative proteomics

Identifiers

PMID32407631
PMCPMC7425200

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.